Skip to content
Search

Latest Stories

Junior doctor strikes likely to end as BMA and government agree on fresh pay offer

Junior doctor strikes likely to end as BMA and government agree on fresh pay offer

From September junior doctors will be referred by their chosen title, Resident Doctors, to reflect their expertise  

The British Medical Association (BMA) and the government have agreed on a new pay offer for junior doctors that, if accepted, could end 15 months of devastating strike action.

The BMA is set to recommend that its members accept this offer, which will deliver an additional pay rise of between 3.71% and 5.05%, averaging 4.05%, on top of their existing pay award for 2023-24. This pay increase will be retroactively applied from April 2023.


Accepting the recommendations of the Review Body on Doctors’ and Dentists’ Remuneration (DDRB) for 2024-25, the government will also uplift each part of the pay scale by 6%, plus £1,000 on a consolidated basis, resulting in an average increase of over 8%, effective from 1 April 2024.

These pay rises will result in a starting foundation training doctor's base pay increasing to £36,600, up from around £32,400. Similarly, a full-time doctor entering specialty training will see their basic pay rise to over £49,900, compared to approximately £43,900 they were paid.

Health and Social Care Secretary Wes Streeting said: “I am delighted that we have agreed an offer that finally paves the way to ending industrial action which has caused untold misery to patients and staff.”

“Everyone agrees we can’t have more disruption, more cancelled appointments, which is why my priority from day one has been to end this dispute.

Since assuming his role, the Health Secretary has prioritised resolving the strike action, initiating discussions with the BMA junior doctors’ committee on his first day in office and meeting with them regularly over the last three weeks.

Streeting noted that although the negotiation had been tough, they had worked rapidly to reach a fair offer.

“I have been honest about the terrible economic inheritance left for this government, while the junior doctors’ committee has been clear that nothing less than the offer on the table will bring these strikes to an end.

“This is a fair offer. Fair to junior doctors, fair to patients and fair to the NHS. It also represents an opportunity to truly reset relationships so we can begin working together to bring waiting lists down and fix the broken NHS,” he added.

Additionally, the government will ask the Review Body on Doctors’ and Dentists’ Remuneration to consider the overall reward package and career progression for resident doctors in its recommendations for 2025-26.

This aims to ensure that medicine remains an attractive and rewarding career path, contributing to the development of future consultants and GPs, according to the Department of Health and Social Care (DHSC).

Acknowledging the disruption caused by the rotation system for junior doctors and their families, the department will lead a review to reform the number and frequency of rotations.

Furthermore, it will review and redesign curriculums where needed. NHS England will assess training numbers to address bottlenecks and ensure the NHS has enough doctors, consultants and GPs for the future.

From September, junior doctors will be referred to as ‘Resident Doctors’ to reflect their expertise.

This is part of the ambition to reset the relationship between the government and NHS doctors, the DHSC stated.

Junior doctors’ strikes have significantly impacted the NHS, with nearly 1.5 million patient appointments canceled or rescheduled, and striking doctors losing many days of pay.

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less